1 Varela J C,Tomlinson S. Complement: an overview for the clinician[J].Hematol Oncol Clin North Am, 2015,29(3):409-427. 2 Uhlmann E J,Shenoy S,Goodnough L T. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion[J].Transfusion,2014,54(2):384-388. 3 Yang L,Ren C,Mao M,et al. Prognostic factors of the efficacy of high-dose corticosteroid therapy in hemolysis,elevated liver enzymes,and low platelet count syndrome during pregnancy:a meta-analysis[J]. Medicine (Baltimore),2016,95(13):e3203. 4 Zwiers C,Scheffer-Rath M E,Lopriore E,et al.Immunoglobulin for alloimmune hemolytic disease in neonates[J].Cochrane Database Syst Rev,2018,3:CD003313. 5 Delaney M,Wendel S,Bercovitz R S,et al.Transfusion reactions:prevention,diagnosis,and treatment[J].Lancet,2016,388(10061):2825-2836. 6 Koshy R,Patel B,Harrison J S.Anti-Kpa-induced severe delayed hemolytic transfusion reaction[J]. Immunohematology, 2009, 25(2):44-47. 7 Ainsworth C D,Crowther M A,Treleaven D,et al. Severe hemolytic anemia post-renal transplantation produced by donor anti-D passenger lymphocytes: case report and literature review[J]. Trans Med Rev, 2009, 23(2):155-159. 8 XIE W,DU L. Diabetes is an inflammatory disease: Evidence from traditional Chinese medicines[J].Diabetes ObesMetab, 2011,13(4):289-301. 9 Emmens R W,Wouters D,Zeerleder S,et al. On the value of therapeutic interventions targeting the complement system in acute myocardial infarction[J]. Transl Res,2017,182:103-122. 10 Robertson J J,Brem E,Koyfman A.The acute hemolytic anemias: The importance of emergency diagnosis and management[J]. J Emerg Med,2017 ,53(2):202-211. 11 Berentsen S. Complement activation and inhibition in autoimmune hemolytic anemia:Focus on cold agglutinin disease[J].Semin Hematol,2018,55(3):141-149. 12 Risitano A M,Notaro R,Marando L,et al.Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab[J]. Blood,2009,113(17):4094-4100. 13 Lauritsch-Hernandez L S,Kraehenmann F,Balabanov S. Eculizumab application during pregnancy in a patient with paroxysmal nocturnal hemoglobinuria:A case report with review of the literature[J]. Clin Case Rep,2018,6(8):1582-1587. 14 Harder M J,Kuhn N,Schrezenmeier H,et al. Incomplete inhibition by eculizumab:mechanistic evidence for residual C5 activity during strong complement activation[J]. Blood,2017,129(8): 970-980. 15 吴彦,吴甘霖.半枝莲多糖抗补体活性研究[J].中国实验方剂学杂志,2009,15(05):49-52. 16 崔昊,孙黔云,杨娟.刺梨多糖的抗补体活性研究[J].贵阳中医学院学报,2009,31(01):22-24. 17 付丽娜,陈兰英,刘荣华,等.白茅根的化学成分及其抗补体活性[J].中药材,2010,33(12):73-75. 18 张学俊,伊廷金,孙黔云.杜仲叶多糖的提取分离、抗补体活性及结构研究[J].天然产物研究与开发,2011,23(6):606-611. 19 张英,周光雄.广藿香的本草考证研究[J].中药材,2015,38(09):1986-1989. 20 阮姝楠,卢燕,陈道峰.广藿香的抗补体活性成分[J].中国中药杂志,2013,38(13):2129-2135. 21 Jin J H,Cheng Z H,Chen D F.Anti-complement constituents of commelinacommunis and their targets in complement activation cascade[J].Journal of Chinese Pharmaceutical Sciences,2012,21(1):577-581. 22 焦杨,邹录惠,邱莉,等.5种马鞭草科药用植物的抗补体活性[J].中国药科大学学报,2016,47(04):469-473. 23 侯灵莉,李松林,闫银萍,等.香椿果抗补体活性成分[J].中国实验方剂学杂志,2017,23(21):52-58. 24 朱芳娟,侯灵莉,孙黔云,等.叶下珠抗补体活性研究[J].中国药理学通报,2018,34(05):686-690. 25 张卫,黄璐琦,李超霞,等.金银花品种的本草考证[J].中国中药杂志,2014,39(12):2239-2245. 26 倪付勇,刘露,宋亚玲,等.金银花中抗补体活性酚酸类成分的研究[J].中国中药杂志,2015,40(02):269-274. 27 李平,胡建燃,史宝忠.潞党参多糖的抗补体活性分析[J].生命科学研究,2018,22(02):136-142. 28 Adatya S,John R,Eckman P M.Treatment of hemolysis with intravenous unfractionated heparin using an antifactor Xa-based monitoring protocol[J]. J Thorac Cardiovasc Surg,2015,149(5):1465-1466. 29 Ferguson D,Kovach A E.Rasburicase-induced hemolytic anemia in previously undiagnosed G6PD deficiency[J].Blood,2018,132(6):673. 30 朱红艳,金华,杨庆莉,等.新生儿ABO 溶血病的早期诊断及治疗[J].中国卫生产业,2014,18( 9) : 151-152. 31 Abdul-Aziz B,Lorencatto F,Stanworth S J,et al. Patients' and health care professionals' perceptions of blood transfusion:a systematic review[J]. Transfusion,2018,58(2):446-455. 32 林静霞,任俊,肖帆,等.输血不良反应的临床特点及影响因素分析[J].中国输血杂志,2015,28(03):291-294. 33 兰炯采,刘志伟,丁志山,等.创建中西医结合中国特色输血医学体系[J].中国输血杂志,2017,30(08):855-858. 34 Weinstock C,Möhle R,Dorn C,et al.Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion[J]. Transfusion,2015,55(3):605-610. 35 曹锦花.茵陈的化学成分和药理作用研究进展[J].沈阳药科大学学报,2013,30(06):489-494. 36 缪频,朱桂莲.中药治疗ABO溶血临床疗效观察[J].中华中医药学刊,2016,34(03):757-759. 37 俞丽平.中药预防母婴血型不合溶血病临床观察[J].新中医,2013,45(08):115-116. 38 李莉华,张静,马印图,等.茵栀黄口服液早期干预治疗Rh血型不合新生儿溶血病临床观察[J].河北医药,2013,35(22):3383-3385. 39 梁洁.茵陈蒿汤联合维生素C治疗IgG抗体高效价孕妇预防新生儿溶血病的临床观察[J].中国临床新医学,2016,9(10):873-875. 40 黄洁,孙荃荟.中药治疗母儿ABO血型不合系统评价[J].中医药导报,2015,21(02):55-59. |